AMGN
Amgen Inc. Healthcare - Biotechnology Investor Relations →
Amgen Inc. (AMGN) closed at $347.80 as of 2026-03-20, trading 30.2% above its 200-week moving average of $267.19. The stock is currently moving closer to the line, down from 37.4% last week. The 14-week RSI sits at 60, indicating neutral momentum.
Trading volume is running at 1.9x of its 14-week average, which is in the normal range. The balance between buying and selling volume (1.01 ratio) is neutral — neither side is clearly dominating.
Over the past 2183 weeks of data, AMGN has crossed below its 200-week moving average 22 times. On average, these episodes lasted 16 weeks. Historically, investors who bought AMGN at the start of these episodes saw an average one-year return of +20.2%.
With a market cap of $187.5 billion, AMGN is a large-cap stock. The company generates a free cash flow yield of 4.0%. Return on equity stands at 106.1%, indicating strong profitability. The stock trades at 21.6x book value.
Over the past 33.2 years, a hypothetical investment of $100 in AMGN would have grown to $6635, compared to $2683 for the S&P 500. That represents an annualized return of 13.4% vs 10.4% for the index — confirming AMGN as a market-beating investment and the kind of quality company where buying during 200-week moving average touches has historically been rewarded.
Free cash flow has been declining at a -2.7% compound annual rate. A deteriorating cash flow trend warrants extra scrutiny — the stock may be cheap for a reason.
Business Health
Annual financials — how the underlying business has performed over the past several years.
Cash Flow Free cash flow & net income ($M)
Revenue Annual revenue ($M) — business growth proxy
Total Debt Balance sheet debt ($M)
ROIC Return on invested capital (%)
FCF Yield Free cash flow / market cap (%) — Yartseva signal
Gross Margin Pricing power & competitive moat (%)
Shares Outstanding Buybacks vs dilution (millions)
Growth of $100: AMGN vs S&P 500
Monthly data normalized to $100 at start. Vertical dashed lines mark 200-week MA touches.
What Happens After AMGN Crosses Below the Line?
Across 21 historical episodes, buying AMGN when it crossed below its 200-week moving average produced an average return of +20.4% after 12 months (median +9.0%), compared to +10.1% for the S&P 500 over the same periods. 71% of those episodes were profitable after one year. After 24 months, the average return was +47.0% vs +22.8% for the index.
Each line shows $100 invested at the moment AMGN crossed below its 200-week MA. Bold blue = stock average. Gray dashed = S&P 500 average over same periods.
Historical Touches
AMGN has crossed below its 200-week MA 22 times with an average 1-year return of +20.2% after recovery.
| Crossed Below | Recovered | Weeks | Max Depth | 1-Year Return | Return Since Touch |
|---|---|---|---|---|---|
| May 1984 | Apr 1985 | 49 | 42.7% | +35.6% | +438683.3% |
| Mar 1993 | Apr 1993 | 6 | 9.0% | +21.8% | +12271.8% |
| May 1993 | Oct 1993 | 20 | 19.9% | +29.8% | +11487.6% |
| Jan 1994 | May 1994 | 15 | 18.7% | +50.1% | +9723.5% |
| Jun 1994 | Jul 1994 | 7 | 9.2% | +56.3% | +8940.9% |
| Apr 2002 | Mar 2003 | 44 | 33.9% | +29.7% | +953.7% |
| Nov 2003 | Dec 2003 | 4 | 3.1% | +3.0% | +782.7% |
| Mar 2004 | Aug 2004 | 21 | 9.0% | +1.5% | +785.2% |
| Sep 2004 | Nov 2004 | 8 | 8.8% | +47.5% | +797.4% |
| Mar 2005 | Apr 2005 | 1 | 0.3% | +26.9% | +796.6% |
| Feb 2007 | Jul 2008 | 74 | 36.9% | -26.3% | +732.7% |
| Sep 2008 | Jul 2009 | 46 | 25.4% | -2.4% | +751.2% |
| Aug 2009 | Sep 2009 | 3 | 1.5% | -12.6% | +762.6% |
| Sep 2009 | Oct 2009 | 1 | 0.9% | -5.2% | +777.8% |
| Oct 2009 | Jan 2010 | 14 | 8.6% | +2.5% | +815.4% |
| Feb 2010 | Mar 2010 | 3 | 1.6% | -4.9% | +810.4% |
| May 2010 | Sep 2010 | 20 | 8.6% | +5.8% | +844.2% |
| Nov 2010 | Dec 2010 | 5 | 1.8% | +6.8% | +844.0% |
| Feb 2011 | Apr 2011 | 11 | 3.4% | +26.6% | +856.8% |
| Aug 2011 | Aug 2011 | 3 | 7.6% | +61.0% | +886.6% |
| May 2023 | Jun 2023 | 3 | 1.5% | +45.4% | +74.5% |
| Jul 2023 | Jul 2023 | 1 | 1.3% | +46.6% | +73.1% |
| Average | 16 | — | +20.2% | — |
Frequently Asked Questions
Is AMGN below its 200-week moving average?
No. Amgen Inc. (AMGN) is currently 30.2% above its 200-week moving average of $267.19. It would need to fall to $267.19 to cross below the line.
What is AMGN's 200-week moving average price?
Amgen Inc.'s 200-week moving average is $267.19 as of 2026-03-20. This is the average weekly closing price over roughly the last 4 years, and it acts as a long-term trend line. When a stock drops below this level, it can signal that the price has fallen far enough from the long-term trend to attract value-oriented investors.
What happens when AMGN drops below its 200-week moving average?
AMGN has crossed below its 200-week moving average 22 times in our data. On average, buying at that moment produced a one-year return of +20.2%. These dips have historically been decent entry points. These episodes lasted 16 weeks on average.
Is AMGN a good value right now?
Here's what our data says about AMGN as of 2026-03-20: The stock is above its 200-week moving average, so it doesn't currently meet our primary signal. The 14-week RSI is 60. Free cash flow yield is 4.0%. Return on equity is 106.1%. Price-to-book is 21.6x. This is not a buy or sell recommendation — always do your own research.
How does AMGN compare to the S&P 500?
Over the past 33.2 years, $100 invested in AMGN would have grown to $6635, compared to $2683 for the S&P 500. That's 13.4% annualized vs 10.4% for the index. AMGN has outperformed the broader market over this period.
Does AMGN pay a dividend?
Yes. Amgen Inc. currently pays a dividend yield of 290.00%.
Not financial advice. This is an educational tool. Past performance does not guarantee future results. Do your own research before making investment decisions.
Data as of week of 2026-03-20